A new drug for pancreas cancer may be a game changer, Elizabeth Tracey reports

Health Newsfeed – Johns Hopkins Medicine Podcasts by Johns Hopkins Medicine

Daraxonrasib is the name of a drug for pancreas cancer that almost doubled survival for people with the disease in a clinical trial. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says while the d...View more